Explore how newer HER2 therapies and anthracycline-sparing regimens cut breast cancer heart damage, with monitoring and cardioprotective drugs.
Mann Patel
Advertisement
Articles by Mann Patel
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Daraxonrasib/Vopimetostat Yields Stunning Response Rate in MTAP-del Pancreatic Cancer
2
FDA Approves Adjuvant Belzutifan/Pembrolizumab in Clear Cell RCC Post Nephrectomy
3
Investigators Halt Phase 3 Trial of Sacituzumab Govitecan Combo in NSCLC
4
Quadruplet Combo Appears Effective in High-Risk Smoldering Multiple Myeloma
5